Ticker
ACONW

Price
0.35
Stock movement up
+- (%)
Company name
Aclarion Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Health Information Services
Market cap
-
Ent value
-5344.75B
Price/Sales
-
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-
3 year return
-
5 year return
-
10 year return
-
Last updated: 2022-08-25

DIVIDENDS

ACONW does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-592.15

FINANCIALS

Per share

Loading...
Per share data
Current share count-
EPS (TTM)-1033.57
FCF per share (TTM)-0.00

Income statement

Loading...
Income statement data
Revenue (TTM)9.03B
Gross profit (TTM)-7.71B
Operating income (TTM)-773.10B
Net income (TTM)-936.09B
EPS (TTM)-1.03K
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-85.38%
Operating margin (TTM)-8565.25%
Profit margin (TTM)-10371.03%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash50.45B
Net receivables12.52B
Total current assets565.48B
Goodwill0.00
Intangible assets1231.59B
Property, plant and equipment0.00
Total assets1807.99B
Accounts payable1.39M
Short/Current long term debt0.00
Total current liabilities8737.59B
Total liabilities-5294.30B
Shareholder's equity7102.29B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-1.08M
Capital expenditures (TTM)173.30K
Free cash flow (TTM)-983.89K
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-13.18%
Return on Assets-51.78%
Return on Invested Capital-13.18%
Cash Return on Invested Capital-

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.35
Daily high0.35
Daily low0.35
Daily Volume0K
All-time high0.75
1y analyst estimate-
Beta-
EPS (TTM)-1033.57
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ACONWS&P500
Current price drop from All-time high-53.52%-13.41%
Highest price drop-82.65%-56.47%
Date of highest drop20 Jul 20229 Mar 2009
Avg drop from high-48.25%-11.38%
Avg time to new high13 days12 days
Max time to new high41 days1805 days
COMPANY DETAILS
ACONW (Aclarion Inc) company logo
Marketcap
-
Marketcap category
Small-cap
Description
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Employees
3
Investor relations
-
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON)(NASDAQ:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physi...
September 19, 2022
Broomfield, Colorado--(Newsfile Corp. - August 4, 2022) - Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW) ("Aclarion" or the "Company"), a healthcare technology company that is leveraging biomarkers and...
August 4, 2022
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
July 22, 2022
Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON)(NASDAQ:ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physi...
July 20, 2022
Superior Clinical Outcomes for NociscanTM Proving to be Durable at Two YearsTwo Year Results and the Schedule of Future Clinical Trials to be Outlined at the Annual State of Spine Surgery Think Tank 2...
June 22, 2022
SAN MATEO, CA / ACCESSWIRE / April 26, 2022 / Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON) (NASDAQ:ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy ...
April 27, 2022
SAN MATEO, CA / ACCESSWIRE / April 21, 2022 / Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON)(NASDAQ:ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy (...
April 21, 2022